3rd Annual MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference ( Time Zone - EASTERN STANDARD TIME (EST)

October 22nd - 23rd, 2020

EVENT OVERVIEW

MarketsandMarkets is proud to announce the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 22nd -23rd, 2020.

While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.

Our aim for the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference is to unite all stakeholders in a virtual room during these remarkable times to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.

The virtual conference will also hold discussion on the impact due to COVID-19 in RWD space- Identifying and overcoming those challenges efficiently

WHAT TO EXPECT

  • Progression on uses of Real-World Data across the ecosystem
  • Global regulatory perspective on Real-World Evidence Guidance- FDA & EMA
  • Applications of Artificial Intelligence & Blockchain for Real-World Data Analysis
  • Market Access and Pricing
  • COVID-19 impact- Identifying and overcoming challenges in Real-World Evidence space

From pharmaceutical and Biopharmaceutical companies-

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologist, within the following departments

  • Real-World Evidence
  • Health Economics & Outcomes Research
  • Patient Access
  • Value Access
  • Clinical Operations
  • Clinical Development
  • Center for Observational and Real-World Evidence  

 

  • Understand the impact of innovative real-world evidence partnerships for better data
  • To explore the capabilities of using Artificial Intelligence & Machine Learning for better Data Analysis
  • Learn about global regulatory perspective on Real-World Evidence Guidance
  • Learn about best practices for the commercial structure of drugs, from development to market access strategy
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by